Palifermin

Palifermin (trade name Kepivance, marketed by Biovitrum) is a truncated human recombinant keratinocyte growth factor (KGF)[1] produced in Escherichia coli. KGF stimulates the growth of cells that line the surface of the mouth and intestinal tract.[2] Contents 1 Therapeutic use(s) 2 Drug target and mechanism of action 3 Side effects 4 Administration 5 Drug interactions 6 Pre-clinical trials 6.1 Toxicology studies 7 Clinical trials 7.1 Phase I 7.2 Phase II ... [wikipedia]